Study for Children with diabetic ketoacidosis admitted to Oishei ICU
Protocol: STUDY00002510
Full Title
A single-center randomized double blind controlled clinical trial of intravenous fluid content in children with diabetic ketoacidosis admitted to the pediatric intensive care unit
Description
This study enrolls children with diagnosed with diabetic ketoacidosis (DKA) who will be admitted to the pediatric intensive care unit (PICU) for treatment. The purpose of this study is to compare the length of time patients have high acid in their blood and how long they have to stay in the hospital with DKA when they are treated with different types of IV fluids in the PICU.

You child will be in this study until their discharge from the PICU. They will be randomly assigned (like the flip of a coin) to receive one of two types of IV fluids, either normal saline or lactated ringers while they are in the hospital until they recover from DKA. The study takes place at Oishei Children's Hospital.

Compensation is not available for this study.
Compensation: No
Eligibility
Children ages 0-18 years old.
Children who present with diabetic ketoacidosis and require pediatric intensive care unit admission.
Age Group: Children
Principal Investigator: AMANDA HASSINGER
Contact(s)
Haiping Qiao
hqiao@buffalo.edu
+1 716-323-0055
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.

Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided in the aforementioned ways, please contact ctsiresearch@buffalo.edu.